S-A Im

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

D-Y. Oh, S-A Im, S.R. Park et al. · British Journal of Cancer · 2009 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer

Hanbo Min, Yoon Jun Kim, D-Y. Oh et al. · British Journal of Cancer · 2008 · 98 citations · Full text

Medicine, Oncology, Pathology +17

Abstract S5-1: Biomarker analyses in CLEOPATRA: A phase III, placebo-controlled study of pertuzumab in HER2-positive, first-line metastatic breast cancer (MBC)

José Baselga, Javier Cortés, S-A Im et al. · Cancer Research · 2012 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +17

The beneficial effect of palliative resection in metastatic colorectal cancer

Jung‐Hyun Park, S-W Han, D-Y. Oh et al. · British Journal of Cancer · 2013 · 57 citations · Full text

Medicine, Oncology, Surgery +16

LBA13 Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (Pts) with HR+/HER2− early breast cancer (EBC): 4-year outcomes from the NATALEE trial

Peter A. Fasching, Daniil Stroyakovskiy, Denise A. Yardley et al. · Annals of Oncology · 2024 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17